4-(2,5-dihydroxy-3-methylpyrrol-1-yl)-N-[5-(3,3-dimethyl-4-oxopentoxy)-2,5-dimethylhexan-2-yl]-4-methylpentanamide
C26H46N2O5 — CID 123211061
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2,5-dihydroxy-3-methylpyrrol-1-yl)-N-[5-(3,3-dimethyl-4-oxopentoxy)-2,5-dimethylhexan-2-yl]-4-methylpentanamide
4-(2,5-dihydroxy-3-methylpyrrol-1-yl)-N-[5-(3,3-dimethyl-4-oxopentoxy)-2,5-dimethylhexan-2-yl]-4-methylpentanamide (PubChem CID 123211061) has the molecular formula C26H46N2O5 and a molecular weight of 466.66 g/mol. Its IUPAC name is 4-(2,5-dihydroxy-3-methylpyrrol-1-yl)-N-[5-(3,3-dimethyl-4-oxopentoxy)-2,5-dimethylhexan-2-yl]-4-methylpentanamide.
Molecular Properties
| Compound Name | 4-(2,5-dihydroxy-3-methylpyrrol-1-yl)-N-[5-(3,3-dimethyl-4-oxopentoxy)-2,5-dimethylhexan-2-yl]-4-methylpentanamide |
|---|---|
| PubChem CID | 123211061 |
| Molecular Formula | C26H46N2O5 |
| Molecular Weight | 466.66 g/mol |
| Exact Mass | 466.34 |
| IUPAC Name | 4-(2,5-dihydroxy-3-methylpyrrol-1-yl)-N-[5-(3,3-dimethyl-4-oxopentoxy)-2,5-dimethylhexan-2-yl]-4-methylpentanamide |
| SMILES | CC(=O)C(C)(C)CCOC(C)(C)CCC(C)(C)NC(=O)CCC(C)(C)n1c(O)cc(C)c1O |
| InChI | InChI=1S/C26H46N2O5/c1-18-17-21(31)28(22(18)32)25(7,8)12-11-20(30)27-24(5,6)13-14-26(9,10)33-16-15-23(3,4)19(2)29/h17,31-32H,11-16H2,1-10H3,(H,27,30) |
| InChIKey | SQPGSKUYLVCTOJ-UHFFFAOYSA-N |
| XLogP | 5.20 |
| TPSA | 100.79 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.66 |
| LogP ≤ 5 | 5.20 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123211061 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.